Back to News
Market Impact: 0.15
Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?
Source: fool.com
Capital Returns (Dividends / Buybacks)Healthcare & BiotechCompany Fundamentals
Pfizer's dividend yield ranks among the highest in healthcare and the S&P 500, while Bristol Myers Squibb has a more comfortable payout ratio. The comparison highlights Pfizer's relatively greater dividend-payout burden; the article provides no specific yield or payout figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
BMY0.10
PFE0.10
More News
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- Boeing 777 freighter output halted for two months over supplier row
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- What a Concept From Nature Tells Us About How C-Suite Executives Actually Think About AI
- How to Track Earnings Call Sentiment Across Companies